BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9647471)

  • 1. Role of hyperthermia in the protective action of clomethiazole against MDMA ('ecstasy')-induced neurodegeneration, comparison with the novel NMDA channel blocker AR-R15896AR.
    Colado MI; Granados R; O'Shea E; Esteban B; Green AR
    Br J Pharmacol; 1998 Jun; 124(3):479-84. PubMed ID: 9647471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo evidence against clomethiazole being neuroprotective against MDMA ('ecstasy')-induced degeneration of rat brain 5-HT nerve terminals by a free radical scavenging mechanism.
    Colado MI; O'Shea E; Esteban B; Granados R; Green AR
    Neuropharmacology; 1999 Feb; 38(2):307-14. PubMed ID: 10218873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the neuroprotective effect of the enantiomers of AR-A008055, a compound structurally related to clomethiazole, on MDMA ("ecstasy")-induced neurodegeneration in rat brain.
    Colado MI; O'Shea E; Esteban B; Green AR
    Psychopharmacology (Berl); 2001 Aug; 157(1):82-8. PubMed ID: 11512047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlormethiazole, dizocilpine and haloperidol prevent the degeneration of serotonergic nerve terminals induced by administration of MDMA ('Ecstasy') to rats.
    Hewitt KE; Green AR
    Neuropharmacology; 1994 Dec; 33(12):1589-95. PubMed ID: 7539115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of the mechanisms involved in the neurotoxic action of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') on dopamine neurones in mouse brain.
    Colado MI; Camarero J; Mechan AO; Sanchez V; Esteban B; Elliott JM; Green AR
    Br J Pharmacol; 2001 Dec; 134(8):1711-23. PubMed ID: 11739248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mechanisms involved in the long-lasting neuroprotective effect of fluoxetine against MDMA ('ecstasy')-induced degeneration of 5-HT nerve endings in rat brain.
    Sanchez V; Camarero J; Esteban B; Peter MJ; Green AR; Colado MI
    Br J Pharmacol; 2001 Sep; 134(1):46-57. PubMed ID: 11522596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine.
    Colado MI; Murray TK; Green AR
    Br J Pharmacol; 1993 Mar; 108(3):583-9. PubMed ID: 7682129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo evidence for free radical involvement in the degeneration of rat brain 5-HT following administration of MDMA ('ecstasy') and p-chloroamphetamine but not the degeneration following fenfluramine.
    Colado MI; O'Shea E; Granados R; Murray TK; Green AR
    Br J Pharmacol; 1997 Jul; 121(5):889-900. PubMed ID: 9222545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA ('ecstasy').
    O'Shea E; Granados R; Esteban B; Colado MI; Green AR
    Neuropharmacology; 1998 Jul; 37(7):919-26. PubMed ID: 9776387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of the mechanism of MDMA ('ecstasy')-induced neurotoxicity of 5-HT neurones using chlormethiazole, dizocilpine and other protective compounds.
    Colado MI; Green AR
    Br J Pharmacol; 1994 Jan; 111(1):131-6. PubMed ID: 7516800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the role of dopamine in the degeneration of 5-HT nerve endings in the brain of Dark Agouti rats following 3,4-methylenedioxymethamphetamine (MDMA or 'ecstasy') administration.
    Colado MI; O'Shea E; Granados R; Esteban B; Martín AB; Green AR
    Br J Pharmacol; 1999 Feb; 126(4):911-24. PubMed ID: 10193771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hyperthermic and neurotoxic effects of 'Ecstasy' (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype.
    Colado MI; Williams JL; Green AR
    Br J Pharmacol; 1995 Aug; 115(7):1281-9. PubMed ID: 7582557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of GBR 12909 and fluoxetine on the acute and long term changes induced by MDMA ('ecstasy') on the 5-HT and dopamine concentrations in mouse brain.
    O'Shea E; Esteban B; Camarero J; Green AR; Colado MI
    Neuropharmacology; 2001; 40(1):65-74. PubMed ID: 11077072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the neuroprotective effect of pentobarbitone on MDMA-induced neurodegeneration.
    Colado MI; Esteban B; O'Shea E; Granados R; Green AR
    Psychopharmacology (Berl); 1999 Mar; 142(4):421-5. PubMed ID: 10229068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-Deoxy-D-glucose prevents and nicotinamide potentiates 3, 4-methylenedioxymethamphetamine-induced serotonin neurotoxicity.
    Hervías I; Lasheras B; Aguirre N
    J Neurochem; 2000 Sep; 75(3):982-90. PubMed ID: 10936179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats.
    Mechan AO; Esteban B; O'Shea E; Elliott JM; Colado MI; Green AR
    Br J Pharmacol; 2002 Jan; 135(1):170-80. PubMed ID: 11786492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated intermittent methylenedioxymethamphetamine exposure protects against the behavioral and neurotoxic, but not hyperthermic, effects of an MDMA binge in adult rats.
    Piper BJ; Ali SF; Daniels LG; Meyer JS
    Synapse; 2010 Jun; 64(6):421-31. PubMed ID: 20169574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The spin trap reagent alpha-phenyl-N-tert-butyl nitrone prevents 'ecstasy'-induced neurodegeneration of 5-hydroxytryptamine neurones.
    Colado MI; Green AR
    Eur J Pharmacol; 1995 Jul; 280(3):343-6. PubMed ID: 8566105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influences of the corticotropic axis and sympathetic activity on neurochemical consequences of 3,4-methylenedioxymethamphetamine (MDMA) administration in Fischer 344 rats.
    Fernandez F; Aguerre S; Mormède P; Chaouloff F
    Eur J Neurosci; 2002 Aug; 16(4):607-18. PubMed ID: 12270036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced efficacy of fluoxetine following MDMA ("Ecstasy")-induced serotonin loss in rats.
    Durkin S; Prendergast A; Harkin A
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1894-901. PubMed ID: 18824064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.